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Abstract
Background: A growing number of countries are introducing some form of nurse prescribing. However,
international reviews concerning nurse prescribing are scarce and lack a systematic and theoretical approach. The
aim of this review was twofold: firstly, to gain insight into the scientific and professional literature describing the
extent to and the ways in which nurse prescribing has been realised or is being introduced in Western European
and Anglo-Saxon countries; secondly, to identify possible mechanisms underlying the introduction and
organisation of nurse prescribing on the basis of Abbott’s theory on the division of professional labor.
Methods: A comprehensive search of six literature databases and seven websites was performed without any
limitation as to date of publication, language or country. Additionally, experts in the field of nurse prescribing were
consulted. A three stage inclusion process, consisting of initial sifting, more detailed selection and checking full-text
publications, was performed independently by pairs of reviewers. Data were synthesized using narrative and
tabular methods.
Results: One hundred and twenty-four publications met the inclusion criteria. So far, seven Western European and
Anglo-Saxon countries have implemented nurse prescribing of medicines, viz., Australia, Canada, Ireland, New
Zealand, Sweden, the UK and the USA. The Netherlands and Spain are in the process of introducing nurse
prescribing. A diversity of external and internal forces has led to the introduction of nurse prescribing
internationally. The legal, educational and organizational conditions under which nurses prescribe medicines vary
considerably between countries; from situations where nurses prescribe independently to situations in which
prescribing by nurses is only allowed under strict conditions and supervision of physicians.
Conclusions: Differences between countries are reflected in the jurisdictional settlements between the nursing and
medical professions concerning prescribing. In some countries, nurses share (full) jurisdiction with the medical
profession, whereas in other countries nurses prescribe in a subordinate position. In most countries the jurisdiction
over prescribing remains predominantly with the medical profession. There seems to be a mechanism linking the
jurisdictional settlements between professions with the forces that led to the introduction of nurse prescribing.
Forces focussing on efficiency appear to lead to more extensive prescribing rights.
Background
The number of countries where nurses are legally per-
mitted to prescribe medication has grown considerably
over the last two decades [1,2]. However, even though
the term ‘nurse prescribing’ suffices as descriptor term,
the actual practice it refers to varies considerably, both
within countries and internationally [3]. Still, interna-
tional comparisons with regard to nurse prescribing are
scarce and those reviews that make an international
comparison either focus on the effects of nurse prescrib-
ing [4], or lack a clear theoretical and systematic
approach [5,6]. A comparative review of the extent of,
and the ways in which nurse prescribing has been rea-
lised or is being initiated internationally, supported by a
sound theoretical model, is lacking. The way in which
prescribing by nurses is organized has far-reaching
* Correspondence: M.Kroezen@nivel.nl
1NIVEL, Netherlands Institute for Health Services Research, PO Box 1568, 3500
BN Utrecht, The Netherlands
Full list of author information is available at the end of the article
Kroezen et al. BMC Health Services Research 2011, 11:127
http://www.biomedcentral.com/1472-6963/11/127
© 2011 Kroezen et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
implications, both for the allocation of jurisdictional
control over prescriptive authority and for the potential
success of nurse prescribing in daily practice. Theoreti-
cal insights can help to shed light on these relationships.
We therefore set out an international systematic review
of publications dealing with the implementation process
of nurse prescribing and current nurse prescribing prac-
tices within Western European and Anglo-Saxon coun-
tries. The theoretical framework used in the review is
based on Andrew Abbott’s theory on the division of
expert labor in modern societies [7].
Traditionally, the task of prescribing medicines has
been the domain of the medical profession [8,9], but the
development of nurse prescribing represents an incur-
sion on the medical profession’s jurisdiction over pre-
scribing. According to Abbott [7], jurisdiction - ‘the link
between a profession and its work’ - forms the central
phenomenon of professional life. Since one profession
can pre-empt another’s jurisdiction or control over a
task, professions exist in an interdependent system with
competing jurisdictional claims. These claims can be
made in several arenas, i.e. professions can claim control
over tasks in the legal arena, the workplace and in the
arena of public opinion.
Abbott [7] extensively discusses the internal and exter-
nal forces that shape professional competition over jur-
isdiction. Examples of external and internal forces that
could possibly shape professional competition over pre-
scribing rights are, respectively, striving for a more cost-
effective healthcare system and a shortage of doctors
within the healthcare workforce [10]. However, ‘there
are only so many full jurisdictions to go around’ [7].
Consequently, most professional conflicts over jurisdic-
tion result in so-called ‘limited jurisdictional settle-
ments’, of which Abbott distinguishes five:
- Subordination: the second most desired outcome
of a jurisdictional conflict, as the incumbent profes-
sion controls the division of labor in which one or
more subordinate groups take their place.
- Intellectual jurisdiction: in which the incumbent
profession controls the cognitive knowledge of an
area but allows practice by other professions.
- Division of labor: in which the jurisdiction over a
certain task is divided between professions into
‘functionally interdependent but structurally equal
parts’.
- Advisory jurisdiction: the weakest form of control,
whereby a profession seeks ‘a legitimate right to
interpret, buffer or partially modify actions another
takes within its own full jurisdiction’.
- Client differentiation: in which segments of a pro-
fession serve different client groups. This is consid-
ered a workplace settlement by Abbott.
Figure 1 shows a graphic and partial representation of
Abbott’s theory, applied to the case of nurse prescribing.
Although this article focuses on the introduction and
realization of legal nurse prescribing, potential jurisdic-
tional claims over prescribing held by one of the
involved professions in other arenas were also included
in our model, since they might influence claims made in
the legal arena. For example in the United States of
America, as Abbott [7] states, it is ‘through public opi-
nion that professions establish the power that enables
them to achieve legal protection’. And as Sampson [11]
states, a strong cohesive nursing community, grassroots
legislative constituency and patient support are crucial
in political battles over prescribing rights. We also
applied Abbott’s potential settlements of a jurisdictional
conflict to the case of nurse prescribing (see Figure 1).
For this purpose, the three general models of (nurse)
prescribing usually distinguished in the literature were
used as a point of departure:
Independent prescribing
Legally permitted and qualified independent prescribers
are responsible for the clinical assessment of a patient,
the establishment of a diagnosis and decisions about the
appropriateness of a medication, treatment or appliance,
including the issuing of a prescription [12,13]. Prescrib-
ing usually takes place from a limited formulary - a list
containing a limited and defined number of medicines
that can be prescribed - or an open formulary. This type
of prescribing is also referred to as initial, autonomous,
substitutive and open prescribing [4,14]. Where nurses
are able to independently prescribe medicines, with a
fair range of prescribing freedom concerning medicine
choice, we considered both the nursing and the medical
profession to hold equal and full jurisdiction over pre-
scribing, according to Abbott’s classification (see Figure
1). It should be noted however that this is an excep-
tional case, as it is very rare for two groups to hold
equal jurisdiction in a particular task area [7].
Supplementary prescribing
Supplementary prescribing is defined as a voluntary
partnership between an independent prescriber - a doc-
tor or a dentist - and a supplementary prescriber -
usually a nurse or a pharmacist. After the initial assess-
ment and diagnosis of a patient’s condition have been
carried out by the independent prescriber, the supple-
mentary prescriber may prescribe from an open or lim-
ited formulary and will collaborate or consult with the
independent prescriber before issuing the prescription,
even though direct supervision is not required [13-16].
Because of the clear delineation of areas of responsibil-
ity, we considered supplementary prescribing as a ‘divi-
sion of labor’ in Abbott’s terms (see Figure 1).
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In the United Kingdom, an important additional fea-
ture of supplementary prescribing is formed by the col-
laboration between the independent and supplementary
prescribers in drawing up a Clinical Management Plan
which needs to be approved by the patient before imple-
mentation [15,16]. Supplementary prescribing is also
known as dependent, collaborative, semi-autonomous or
complementary prescribing [4,14].
Patient group directions
Patient group directions (PGDs), formerly known as
group protocols, refer to written instructions for the
supply and administration of named medicines in an
identified clinical situation [4,14,17,18]. Drawn up by a
multidisciplinary team, they are specifically designed for
a particular group of patients with a specific condition,
thus excluding individualised prescriptions [19]. Group
protocols should not be seen as independent prescrib-
ing, since nurses or other health care professionals are
only allowed to supply and administer medications
within the strict terms of a predetermined protocol,
albeit using their own assessment of patient need
[16,18]. Because PGDs are developed by a multidisci-
plinary team - usually consisting of doctors, pharmacists
and nurses - we considered the ‘intellectual jurisdiction’
over the prescribing task to lie with the team, according
to Abbott’s classification, even though the nurse per-
forms the actual task (see Figure 1).
Following Ryan, Cash and Hannis [20], ‘time and dose
prescribing’, a fourth model sometimes distinguished in
the literature, was not considered as a form of nurse
prescribing in this review, as nurses are only allowed to
alter the time and/or dosage of a particular medication.
Furthermore, whilst the use of PGDs is not an actual
form of prescribing, we nevertheless decided to include
PGDs as a third model of prescribing in our study, con-
sidering their omnipresence in much of the nurse pre-
scribing literature. Moreover, when using PGDs nurses
do make a decision that refers to the medication itself,
whereas with time and dose prescribing the decision to
start with a particular medication has already been taken.
This article reports on the findings of a systematic
review of the scientific and professional literature con-
cerning nurse prescribing. The review is the first phase
in a larger research project focussing on nurse prescrib-
ing and has a twofold aim. Firstly, to gain insight into
the scientific and professional literature describing the
extent to and the ways in which nurse prescribing has
been realised or is being initiated in Western European
and Anglo-Saxon countries. Secondly, to propose possi-
ble mechanisms underlying the organisation of nurse
prescribing internationally, and relate these to Abbott’s
theory on the division of expert labor [7].
The following questions were addressed:
1. To what extent has nurse prescribing of medicines
been initiated or already realised in Western Eur-
opean and Anglo-Saxon countries?
2. As a result of which external and internal forces
has nurse prescribing been initiated or already rea-
lised in Western European and Anglo-Saxon
countries?
         
 
External     SYSTEM OF PROFESSIONS      Internal forces 
forces    built around the task of prescribing medicines 
 
  Interprofessional  Jurisdictional   Jurisdictional 
  competition   arenas   settlements  
 
         - (shared) full jurisdiction; 
  Profession 1        independent prescribing 
  Medical profession        legal public  - subordination 
           - intellectual jurisdiction; 
             JURISDICTION    use of PGDs 
Profession 2      - division of labor; 
Nursing profession                workplace    supplementary prescribing 
- advisory jurisdiction 
         - client differentiation 
Figure 1 Graphic and partial depiction of Abbott’s theory applied to the case of nurse prescribing.
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3. Under which legal, educational and organizational
conditions are nurses allowed to prescribe medicines
within Western European and Anglo-Saxon countries?
4. Which jurisdictional settlements can be discerned
between the medical and nursing professions con-
cerning the task of prescribing medicines?
5. Which mechanism, if any, can be discerned between
the forces that lead to the introduction of nurse pre-
scribing and the resulting jurisdictional settlements
between the medical and nursing professions?
Methods
Search strategy
The following six electronic databases were searched
without any limitation as to date of publication or lan-
guage: PubMed, Embase, CINAHL, Web of Science,
EBSCO Academic Search Elite and the NIVEL-catalo-
gue. Searches were highly sensitive, using the following
search strategy for PubMed: ("Nurse prescribing”) or
(Nurs* [tiab] AND Prescri* [tiab]) or (Nurses [MeSH]
AND “drug prescriptions” [MeSH]) or (Nurses [MeSH]
AND formulary [tiab]). Suitable search strategies were
developed for the other databases, using adaptations of
the PubMed search. All detailed search strategies can be
found in additional file 1 ‘Search strategies’.
In addition to the electronic databases, the following
relevant websites were searched: the website of the Vir-
ginia Henderson International Nursing Library http://
www.nursinglibrary.org, the website of the World Health
Organization http://www.who.int, websites for health
professionals http://www.nurse-prescriber.co.uk, http://
www.nursingtimes.net, http://www.escriber.com, http://
www.internurse.com and Google Scholar http://scholar.
google.com. Since most of these websites lacked
advanced search facilities, the following keywords were
used to search for relevant publications: “nurse prescrib-
ing”, “independent (nurse) prescribing”, “autonomous
prescribing” “supplementary (nurse) prescribing”,
“dependent (nurse) prescribing”, “collaborative prescrib-
ing”, “group protocols” “patient group directions”, “time
and dose prescribing”, “nurse formulary” and combina-
tions of these keywords. All detailed search strategies
can be found in additional file 1 ‘Search strategies’.
Additionally, we consulted experts in the field to identify
any studies that might have been missed.
The hits of all searches were entered into Reference
Manager©; duplicates were sifted out in this program,
and the inclusion process was executed thereafter.
Study selection
Publications from 2005 onwards had to fulfil all of the
following criteria in order to be included:
1) The publication concerns a situation in which
legal nurse prescribing of medicines is being initiated
or has already been realised. We considered legal
nurse prescribing as ‘being initiated’ if at least a
change in the law, or new legislation enabling nurses
to prescribe medicines was in preparation, either at
national, provincial or state level.
2) The publication addresses legal nurse prescribing
of medicines within the geographical context of at
least one Western European or Anglo-Saxon coun-
try. Since the definition of Western Europe is com-
plex and carries economic and cultural connotations,
we adopted the definition of the renowned National
Geographic Society.
3) The publication specifies either the external or
internal forces under which legal nurse prescribing
has been initiated or realised, or the legal, educa-
tional or organizational conditions under which
nurses are allowed to prescribe medicines.
4) The group of professionals with prescribing rights
discussed in the publication includes registered
nurses (but not Physician Assistants).
5) The publication is a professionally or scholarly
‘sound’ publication, i.e. a scientifically peer reviewed
publication or a publication by a government body
or professional association.
Because we aimed to describe nurse prescribing as it is
currently being initiated or has been realised in Western
European and Anglo-Saxon countries, publications from
2005 and later had to meet all the inclusion criteria.
However, in view of our comparative theoretical frame-
work, we were also interested in the external and internal
forces that led to the introduction of nurse prescribing
and which influence the system of professions and the
division of jurisdictions between professions. As these
forces are mainly found in publications dating from the
period of introduction, and nurse prescribing has been
established in some countries for years, publications
prior to 2005 were also included in the review. However,
as our review is only concerned with contemporary nurse
prescribing practices, publications prior to 2005 did not
have to fulfil the second part of inclusion criterion 3, i.e.
they did not have to address the conditions under which
nurses are allowed to prescribe medicines.
Publications were excluded if:
1) They focussed on legal nurse prescribing in coun-
tries other than Western European and Anglo-Saxon
countries.
2) They exclusively related to legal nurse prescribing
of appliances and dressings and made no reference
to legal nurse prescribing of medicines.
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3) They only concerned nurse prescribing by speci-
fied group protocols that severely limit the prescrib-
ing rights of nurses, more specifically group protocols
for (emergency) contraception, child and travel vacci-
nations and annual influenza vaccinations.
4) They merely related to time and dose prescribing.
5) They focussed solely on illegal rather than legal
nurse prescribing of medicines.
6) They only discussed the prescribing rights of mid-
wives and/or nurses holding midwifery credentials -
the latter only if their prescribing rights were based
on their midwifery credentials or if uncertainty
existed about the underpinning of their prescribing
rights.
In some cases the boundary between nurses and mid-
wives proved blurred, for example in the case of the
American certified nurse-midwife, who is an advanced
practice nurse with specialized education and training in
both nursing and midwifery. We adopted a consistent
approach to this issue and excluded all midwives from
the review. Specialised nurses working in an obstetrics
department without holding a midwifery certification
were included.
A three-stage inclusion process was applied. All refer-
ences found in the literature search of databases and
websites were initially studied independently by title and
abstract by pairs of reviewers (MK, ALF and LvD) and
included in the study if they met the above mentioned
criteria. All references deemed eligible for inclusion by
at least one reviewer proceeded to the next selection
round.
In the second stage, pairs of reviewers (MK, ALF and
LvD) independently examined the remaining references
once more by title and abstract. References from 2005
onwards that - on closer scrutiny - did not meet all
inclusion criteria were excluded. All references prior to
2005 that did not explain the external or internal forces
under which nurse prescribing was initiated or realised
were likewise excluded. Again, all references deemed eli-
gible for inclusion by at least one reviewer were
included. However, because of the abundance of UK-
based references selected in the first two stages, and the
large number of internal and external forces mentioned
in these references, the first author, after discussion
with the other two reviewers, excluded all UK-based
references prior to 2005 from the review before turning
to the final selection round.
In the final stage, the full text of all remaining publi-
cations was obtained. Pairs of reviewers (MK, ALF and
LvD) independently studied each publication in order to
determine whether it fulfilled the inclusion criteria, and
disagreements were resolved by discussion.
Where several publications were based on the same
study, containing identical information, the first author
only selected the most recent as well as the most ela-
borative publication for final inclusion in the review.
Additional step during study selection
During the study selection process, the first reviewer
drew up a list containing all Western European and
Anglo-Saxon countries referred to in the titles and
abstracts of the initial search results as having initiated
or realised nurse prescribing. It was assumed that coun-
tries missing on the resulting list had not initiated or
realised nurse prescribing. To make sure that this divi-
sion into ‘prescribing’ and ‘non-prescribing’ countries
corresponded with the current state of affairs across
countries, we verified our findings with representatives
of leading national nurses and medical associations and
government representatives.
Data synthesis and analysis
The first author (MK) extracted data from the included
publications onto digital structured data-extraction
forms, and two other authors (ALF and LvD) checked
the extracted data. Disagreements were resolved by dis-
cussion between the review authors. Data were extracted
on country, external and internal forces that led to the
introduction of nurse prescribing; the educational and
organizational criteria that must be fulfilled in order for
nurses to prescribe medicines; the legal conditions in
place; the financial issues with regard to nurse prescrib-
ing and; where appropriate, the models of nurse pre-
scribing being used.
We used Abbott’s theory on the division of labor as a
point of departure to organize and summarize the data.
Abbott pays considerable attention to the internal and
external forces that shape professional competition over
jurisdiction - in this case the jurisdiction over prescrip-
tive authority. Moreover, he proposes a number of ‘jur-
isdictional settlements’ that are easily compatible with
the three general models of nurse prescribing usually
distinguished in the literature. These models mainly
focus on the legal conditions in place. As educational
and organizational conditions further determine the
organization of nurse prescribing and hence the out-
comes of jurisdictional conflicts, data were eventually
organized under the following broad themes: forces
related to the introduction of nurse prescribing; legal
conditions under which nurse prescribing of medicines
will be or has been realised; educational conditions
under which nurse prescribing of medicines will be or
has been realised; and the organizational conditions
under which nurse prescribing of medicines will be or
has been realised.
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Results
Search and inclusion results
After duplicates had been removed, the searches
resulted in an initial set of 7965 references of potential
interest. Following a first sifting based on title and
abstract, 1484 references were selected for more detailed
scrutiny by title and abstract. The resulting set of 464
articles was ordered in full text. After application of the
inclusion criteria, 167 studies were deemed eligible for
inclusion, of which 5 publications contained duplicate
information by the same author and 38 publications did
not live up to our ‘soundness’ criteria. Finally, 124 publi-
cations were selected for the next stage of the review,
for data-extraction and analysis. Figure 2 shows the flow
diagram of the inclusion process.
Characteristics of the final 124 publications
Countries of interest
Additional file 2 ‘Characteristics of included publica-
tions’ provides a descriptive overview of all included
publications. The majority of included publications
focussed on one country (N = 99) [21-119]. Of these,
seventy-five publications were based in the United King-
dom, ten in the United States of America, five in New
Zealand, four in the Netherlands, two in Ireland and the
rest in Australia, Canada or Sweden. Twenty-three pub-
lications made reference to multiple countries, almost
always including the UK and the USA [120-142]. Just
two international comparative nurse prescribing publica-
tions were included in the review, covering 10 and 12
countries respectively [5,6].
As said before, it was assumed that countries not men-
tioned in the titles and/or abstracts of the search results
had not initiated or realised nurse prescribing. We
checked our findings regarding ‘nurse prescribing coun-
tries’ with relevant stakeholders across Western European
and Anglo-Saxon countries (see additional file 3: Results
of verification literature search with relevant stakeholders
in Western European and Anglo-Saxon countries). This
proved fruitful, as we were informed that an implementa-
tion process for nurse prescribing is currently being rolled
out in Finland. However, since no literature on Finland
was identified through our search strategy, Finland will
not feature in our results section. From all other Western
European and Anglo-Saxon countries that were not identi-
fied with our literature search, we received confirmation
that nurses are indeed not allowed to prescribe medicines
and no implementation process is being initiated.
Date and type of publications
Most publications were published in 2008 and 2009.
The oldest publication included in the review dates
from 1982 and the most recent ones from 2010.
Publications were derived from a variety of sources,
including fifty-five journals and magazines, four books
and three reports.
Main focus of publications
There was much diversity as to the main focus of the
included publications. Nevertheless, a number of recur-
ring themes could be discerned, such as the views of
nurses, doctors and other parties involved concerning
nurse prescribing [45,47,51,53,81,94,108,109,115
,121,139], prescribing behaviours of nurses [36,43,124
,126,128,129,131,137], and nurse prescribing in relation
to specific diseases [38,44,84,89,91-93,101,108,116,125] -
most notably concerning nurse prescribing in mental
health care [21,32,39,67,76,83,100,102,104-106,132,135].
Also, a number of publications focussed on the history
and evolution of (nurse) prescribing of medicines, but
these remained relatively limited [5,6,46,48,49,75
,90,96,103,142].
Nurse prescribing themes discussed
Four broad themes were considered to be relevant for
the organization of nurse prescribing internationally and
the outcomes of jurisdictional competition over the pre-
scription of medicines. All publications were labelled
with appropriate themes (see additional file 2: Charac-
teristics of included publications). Table 1 provides an
overview of publications per theme. The content of
these themes will be discussed later. Additional file 4
provides a descriptive overview of nurse prescribing
across Western European and Anglo-Saxon countries at
national level.
Initiation and realization of nurse prescribing
Year of introduction
It is notable that nurse prescribing was introduced at very
different points in time in the seven Western European
and Anglo-Saxon countries that have so far realised nurse
prescribing, viz. Australia, Canada, Ireland, New Zealand,
Sweden, the United Kingdom and the United States of
America. While nurse prescribing has been in place in the
USA since the 1960s [5,6,30,107,115,123,128,134,135,138],
it is a relatively new phenomenon in most other countries.
Table 2 presents an overview of the (expected) year of
introduction of nurse prescribing in Western European
and Anglo-Saxon countries. While community nurses
were the first group of nurses to start prescribing in the
UK in 1998, one should note that in the years thereafter
two other models of nurse prescribing were introduced
there: in 2002 the form now known as ‘independent pre-
scribing’ was implemented [5,6,24,32,48,49,56,68,72,7
6,84,87,100,101,121,124,136], followed by ‘supplementary
prescribing’ in 2003 [5,6,24,26,27,32,35,36,40,42,46,47,49
Kroezen et al. BMC Health Services Research 2011, 11:127
http://www.biomedcentral.com/1472-6963/11/127
Page 6 of 17
,52,56,62,67-69,72,76,78,81,83,91-94,101,104,121,123,124,-
136,138]. Currently, nurses in the Netherlands are await-
ing for the final amendments to legislation to enable
them to start prescribing [5,58,117,118], and in Spain the
legal regulation of nurse prescribing is in the procedural
phase [5].
Forces related to the introduction of nurse prescribing
External and internal forces which led to the introduc-
tion of nurse prescribing were mentioned in hundred
and two of the hundred and twenty-four publications
included. In the Netherlands, the aim of task realloca-
tion in the health care sector and more particularly the
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undesirable situation in which nurses prescribe medi-
cines on an illegal basis, have been the main driving
force behind the introduction of nurse prescribing
[117,118]. The objective of creating quicker and more
efficient patient access to medicines has also been highly
influential in the introduction process of nurse prescrib-
ing internationally, especially within the UK and Ireland
[21,25,26,29,31,32,34-37,39,42,46,47,51,52,55,58,61,62,64-
,67,69,76,82-84,87,89,90,94,100,102,104,106,112,114]
[116,120,128,132,135-137,140]. Another important force
in this process has been the aim to make better use of
nurses’ skills and knowledge, and to improve the use of
both health professionals’ and patients’ time
[5,6,23,26,30,34,37,39,41,42,44,46,47,51,52,55,56,60,64,66-
-69,73-76,79,84,86,87,89,90,92,93,100,102,103,106,109]
[115-118,124,125,130,132-134,137]. Whereas these seem
to have been the main drivers behind the introduction
of nurse prescribing in the UK and Ireland, forces origi-
nating from within the health professions appear to
have prevailed in other countries. In Australia, Canada,
New Zealand, Sweden and the USA nurses were granted
prescribing rights in order to reduce the workload of
doctors and physicians, address the shortage of physi-
cians - partly resulting from the growing specialisation
of health professionals - and meet the medication needs
of patients in remote areas who were often suffering as
a result of a shortage of physicians [5,6,22,28,30,33,34,41
,51,59,61,85,85,86,107,120-122,124,125,127,128,131,135,-
138]. Moreover, prescriptive authority for nurses in
Canada, New Zealand and the USA followed the devel-
opment of advanced practice nurse (APN) roles
[5,61,74,124], which clearly connects their prescribing
privileges with internal developments within the nursing
profession.
Legal conditions regarding nurse prescribing
All Western-European and Anglo-Saxon countries that
have realised or initiated nurse prescribing have
imposed legal restrictions on which categories of nurses
can prescribe medicines, what, how much and to whom
they can prescribe, and whether they are allowed to do
so on an independent basis or under the supervision of
a physician. In most countries, these issues are regulated
at national level, but in some, such as Australia, Canada
and the USA, prescriptive authority is regulated at fed-
eral, state or regional level [5,6,28,85,125,129,131].
Table 3 offers an overview of prescriptive authority for
nurses across Western European and Anglo-Saxon
countries. Independent prescribing rights were granted
Table 1 Identified themes of nurse prescribing
Nurse prescribing theme Studied by
Internal and external forces
related to the introduction of
nurse prescribing
[5,6,21-42,44-47,51,52,54-56,58-69,73-76,79-90,92-94,96,97,100,102-104,106-112,114-118,120-125,127,128,130-138,140-142]
Legal conditions under which
nurse prescribing of





which nurse prescribing of






prescribing of medicines will
be or has been realised
[5,6,22,23,27,29,40,42,46,47,50,55,64,65,69,71,72,77,79,85,89,91,92,95,99,116,125,128,129,135,137,142]
Table 2 Year of introduction of nurse prescribing
Year of introduction Country
1960s United States of America [5,6,30,107,115,123,128,134,135,138]
Early 1990s Canada [6]
1994 Sweden [5,6,85,112,125,127,136]
1998 United Kingdom [5,6,25,27,40,42,46,48,56,57,62,67-69,72,76,78,85,98,100,101,104,114,116,122,135]
2000 Australia [5,129]
2001 New Zealand [5,6,122,138]
2007 Ireland [5,55,115,139]
Expected in the near future The Netherlands [5,117,118]
Expected in the future Spain [5]
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to nurses across all countries that have introduced nurse
prescribing or are set to do so in the (near) future.
Some countries introduced other models of nurse pre-
scribing as well, such as supplementary or collaborative
prescribing - prescribing in partnership with a physician
- or the use of Patient Group Directions (PGDs) or
medical directives by nurses to supply and administer
medicines to patients [6,24,27,39,40,61,64,71
,72,78,105,128]. For example, in over half of the US
states nurses have full independent prescriptive author-
ity, whereas in other states mandatory collaboration
with and/or supervision by a physician is required
[5,6,28,54,59,75,96,124,135,137]. Likewise in the Nether-
lands in the future, Nurse Specialists will be allowed to
prescribe on an independent basis, although this author-
ity will be limited to a maximum ‘experimental period’
of five years [117], while specific categories of specialist
nurses will prescribe through a model resembling sup-
plementary prescribing [118].
Even though nurses in all countries are (or will be)
allowed to prescribe medicines on an independent basis,
their scope of practice or freedom to act varies consider-
ably, depending on whether or not protocols and/or for-
mularies are in place and if so, how restrictive these are.
In Ireland nurse prescribers may independently pre-
scribe from an open formulary specific to their field of
clinical practice [5,139] whereas in the UK independent
prescribers can prescribe from the entire British
National Formulary (BNF), including unlicensed medi-
cines and some controlled drugs [5,24,26,35,44-46,
48,49,51-53,63,65,68,69,76,78,83,84,92,94,100-103,105,10-
8,109,113,126,128,136,137,139]. Supplementary prescri-
bers in the UK can in addition prescribe all controlled
drugs, provided they are listed in a clinical management
plan agreed by the independent prescriber, nurse and
patient
[5,21,24,26,27,35,38,40,43-45,48-53,63,76,78,82,95,100,10-
1,108,114,123-126]. Community practitioner nurse pre-
scribers in the UK however, have their own more
limited formulary to prescribe from [5,27] and in South
Australia, every nurse practitioner has their own indivi-
dual formulary of medicines from which to prescribe
[129]. Most Australian states however, just as a number
of American states, Canadian provinces and Sweden,
have general limited formularies for nurse prescribers in
place [5,6,28,85,90,112,125-127,136]. Other commonly
used means to restrict nurses independent prescriptive
authority are protocols. The Australian states of New
South Wales and Queensland, a number of American
states, Canadian provinces and the Netherlands all (will)
use protocols in enabling nurse prescribing
[28,58,61,118,119,133].
When it comes to legal restrictions regarding patients
and/or medical conditions for which nurses are allowed
to prescribe medicines, the UK has granted nurses the
most extensive prescription privileges. Community prac-
titioner nurse prescribers can prescribe for a number of
common conditions, but both independent and supple-
mentary nurse prescribers can prescribe for any medical
condition or patient group within their clinical compe-
tence [5,25,27,35,40,50,52,63,68,69,71,78,84,89,92,94,95,
100-102,105,109]. A PGD can in principle also be drawn
up for any medical condition, but should be reserved for
those situations where it offers ‘an advantage for the
patient without compromising patient safety’ [40,72]. In
most other countries however, restrictions apply. In
Sweden, only district nurses and nurses working in
elderly care may prescribe for 60 conditions
[5,6,85,125,127,136] and in Ontario (Canada) nurses can
only prescribe in primary care, long-term care and out-
patient clinics [61]. In New Zealand, prescriptive author-
ity was for a long time granted only to nurses working
in specific areas of care [90,125,138,139] but this
recently appears to have been expanded to include the
whole NP scope of practice [5].
The formal responsibilities that nurse prescribers carry
are clearly defined in most Western European and
Anglo-Saxon countries. For example, in the Canadian
province of British Columbia, registered nurses who
initiate medicines are ‘fully responsible and accountable’
for their prescription [61], and in Massachusetts (USA)
nurses likewise assume responsibility for prescribing
[134]. As the prescription of medicines forms just one
element in the medical care of a patient, formal respon-
sibilities are also established for the related tasks in the
treatment process, viz. accountability and responsibility
for the clinical assessment of a patient and the establish-
ment of a diagnosis. In Australia, for example, nursing
Table 3 Prescriptive authority for nurses in Western


















* Intended form(s) of prescriptive authority, nurse prescribing is not yet legal
(see table 2)
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curricula focus on ‘taking full responsibility for patient’s
treatment’ [5]. In the UK, responsibility for the various
aspects of the treatment process differs between the
three categories of nurse prescribers. Independent nurse
prescribers and qualified community nurse prescribers
are responsible for the clinical assessment and diagnosis
of a patient and for decisions about the clinical manage-
ment required, including prescribing [27,40,47,48,51
,56,69,72,78,83,84,89,92,100,102,108-110,114,124-126,13-
6-138]. Supplementary prescribers, however, are only
responsible for the continuing care of a patient, includ-
ing prescribing, whilst the collaborating independent
prescriber shares the responsibility for prescribing and
holds full responsibility for the assessment and diagnosis
of a patient [25,40,47-49,51,56,63,69,72,78,84
,100,103,123,124,135]. In the Netherlands likewise, spe-
cialist nurses are only allowed to prescribe medicines
after a diagnosis has been made by a doctor [118].
Educational conditions regarding nurse prescribing
In all Western European and Anglo-Saxon countries
that have realised legal nurse prescribing, nurses are
required to successfully complete a prescribing course
before they are allowed to start prescribing
[55,88,107,112,114,122,123,131,134,137-139,141,142].
However, no specific training is required for UK nurses
using PGDs, although most individual Trusts provide
some in-house training [24,39,40,105].
Regarding the place that nurse prescribing training
occupies within the various national education systems
and the level at which it is provided, there are differ-
ences between countries. Education programmes for
nurse prescribing in Ireland as well as independent and
supplementary prescribing courses in the UK, which are
combined into a ‘dual qualification’ [5,32,33,44
,51,53,64,72,93,110,116,122-126], are offered on a stand-
alone basis, i.e. they are not part of a regular nursing
curriculum. However, training to prescribe from the
British Nurse Prescribers Formulary for Community
Practitioners is incorporated into Specialist Practitioner
Programmes [5,6,22,27,40,49,107,138] and in Sweden
prescribing training is part of the Primary Health Care
Specialist Nursing programme, undertaken by all district
nurses [5]. In the Netherlands, it is anticipated that
independent prescribing for Nurse Specialists will
become an obligatory component of the Masters pro-
gramme of Advanced Nursing Practice [5,117], just as in
New Zealand where preparation courses for nurse pre-
scribing are offered within a Masters programme for
advanced nursing practice or as a stand-alone Post
Graduate Diploma (Prescribing) for nurses who already
completed a Masters [5,6,22,27,40,49,107,138].
There are also differences between countries regarding
the educational level of nurse prescribing training.
Where most countries, including Australia, Canada,
New Zealand, the Netherlands and the USA require
nurses to complete a master level degree before they are
allowed to prescribe independently, the Irish nurse pre-
scribing training is awarded at level 8 in the Irish educa-
tion system - which is comparable to Honours Bachelor
Degree level - and in the UK prescribing courses are
taught at undergraduate level 3 (degree level)
[5,6,24,27-29,37,48,50,52,53,56,60,63-65,69,72,76,77,79,8-
4,88,89,91,95,99,107-109,116,120,122-125,131]
[134,137,138,140-142]. This is remarkable when we
recall that nurses in Ireland and especially nurses in the
UK have very broad independent prescribing rights. In
the Netherlands, specialist nurses who will prescribe
through a model resembling supplementary prescribing
will be trained at Bachelor degree level [118].
Criteria to enter prescribing courses are relatively
similar across countries. One of the most important
requirements for nurses internationally to enter pre-
scribing programmes is sufficient clinical experience.
However, the minimum number of years of clinical
experience required varies. In Ireland and the UK, three
years of clinical experience are required [5,29,42,53
,71,84,108,109,124,126,137,140], whereas in New Zeal-
and, nurses must have at least four years of clinical
experience in their speciality area [107,122]. In Australia
as of January 2010, nurses must have five years of clini-
cal experience in their own field of practice, before they
are eligible for endorsements as a nurse practitioner and
hence for prescribing medicines [5]. Thus, it seems that
the UK and Ireland have lower educational- and clinical
experience requirements in place for nurse prescribing
than other Western European and Anglo-Saxon
countries.
Another important requirement that often needs to be
fulfilled, for example in Australia [131], New Zealand
[107] and the UK [37,38,42,53,65,84,95,99,137], is the
ability of nurses to demonstrate clinical assessment and
clinical decision-making skills. In the UK, additional
prerequisites for potential nurse prescribers include
nurses’ ability to arrange for a Designated Medical Prac-
titioner (DMP) who will supervise them during their
practice period and they must occupy a post in which
nurse prescribing will enhance patient care
[5,26,40,50,52,53,77,95,97,108,109,125].
The content of training programmes for nurse pre-
scribing seems to be fairly similar across countries.
Swedish nurses attend lectures on pharmacology, phar-
macovigilance (PV/PVG) and adverse drug reaction
(ADR) reporting [5]. In Australia [5], Ireland [5], New
Zealand [5,122,138] and the UK, pharmacology likewise
constitutes an important topic in the prescribing train-
ing, just as the legal and ethical aspects of prescribing
and clinical decision making [5,48-50,52,110,114,122
,124,125,132,136]. In the literature, assessments
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performed during or at the end of the prescribing
course were only specified for the British situation and
could therefore not be compared across countries. In
the UK these include the completion of a portfolio and
an assessment of nurses’ calculation skills, on which a
100% score must be attained for independent and sup-
plementary prescribing
[5,21,29,38,40,50,52,89,100,113,116,122,127].
Organizational conditions regarding nurse prescribing
The organizational conditions under which nurses are
allowed to prescribe medicines in Western European
and Anglo-Saxon countries are much less discussed in
the literature than educational and legal conditions for
nurse prescribing. It is nonetheless clear that most
countries operate some sort of mandatory registration
system in which nurse prescribers have to be registered
before they are allowed to prescribe. In Australia, nurses
have to submit a formulary of all the medicines they
may prescribe to their respective Nursing Boards as part
of their endorsement process [5,88]; in the Netherlands
prescribing nurses must be registered in the ‘BIG’ regis-
tration system kept by the Ministry of Health [117,118];
and in Ireland [5,115,139], New Zealand [5,6,79], the
UK [5,22,23,29,38,42,71,77,85,91,92,95,116,142] and the
USA [134] nurse prescribers must register their qualifi-
cation with their respective national regulatory nursing
bodies.
In the UK, the Nursing and Midwifery Council (NMC)
together with the National Prescribing Centre (NPC),
have defined the ‘standards of proficiency that underpin
principles of prescribing practice’ [27,87,137], and sev-
eral UK-based publications refer to nurses’ responsibility
to maintain and update their prescribing knowledge,
known as continuing professional development
[5,32,33,35,40,50,60,62,89,136]. These topics nevertheless
draw little attention in the literature and are virtually
absent in publications relating to the other Western
European and Anglo-Saxon countries that have realised
nurse prescribing, with the exception of Ireland and
New Zealand where continuing education and develop-
ment are also being stressed [5].
The financial aspects of nurse prescribing were
touched upon in a mere nine publications. In the UK,
funding to undertake nurse prescribing training is made
available from central government through local level
organizations, such as workforce development confed-
erations, strategic health authorities and local NHS
Trusts [40,42,46,47,65,69,72]. However, medical supervi-
sors of nurses during their practical training period in
the prescribing course are generally not financially
rewarded for their support [40,99]. Moreover, in the
UK, access to a prescribing budget needs to be created
for nurse prescribers before they can perform their role
[40,85]. Another important point that has scarcely been
touched upon in the literature is the reimbursement of
prescriptions written by nurses. In New Zealand, if a
nurse practitioner prescribes a medicine, the costs to
the patient are the same as if a doctor prescribes [129].
However, in several states of the USA, the social welfare
program Medicaid does not reimburse prescriptions
written by nurses [135].
Discussion
Nurse prescribing of medicines is a major area of inter-
est in the scientific as well as professional literature, as
shown by the high number of identified publications.
This review provides insight into the diversity of exter-
nal and internal forces which led to the introduction of
nurse prescribing in the nine identified Western Eur-
opean and Anglo-Saxon countries, while shedding light
on the variety of legal, educational and organizational
conditions in place. Moreover, by applying Abbott’s the-
ory on the division of labor in modern societies, a vari-
ety of jurisdictional settlements between the nursing and
medical professions concerning the task of prescribing
were discerned.
Models of nurse prescribing and jurisdictional settlements
In the introduction to this article we briefly discussed
the three general models of (nurse) prescribing usually
distinguished in the literature, viz. independent prescrib-
ing, supplementary prescribing and the use of patient
group directions (PGDs). However, these models appear
to be largely based on the situation in the UK and may
be less applicable to nurses’ prescriptive authority in
other Western European and Anglo-Saxon countries.
For example, we found that nurses in Sweden and
Ontario are only allowed to independently prescribe for
a limited number of medical conditions. Hence, their
prescribing practices do not fit with the common defini-
tion of ‘independent prescribing’ in which nurses enjoy
unrestricted independent prescribing freedom with
regard to medical conditions.
However, broadly speaking, all nine Western European
and Anglo-Saxon countries identified in this review
grant some form of independent prescribing authority
to nurses, albeit with varying levels of autonomy. But
where we considered ‘independent prescribing’ in the
introduction as a situation in which both the nursing
and medical professions hold equal and full jurisdiction
over prescribing, according to Abbott’s classification,
this does not hold for all countries. Only in Ireland and
the UK, where nurses’ scope of prescribing practice is
fairly extensive, did the level of autonomy prove suffi-
cient to consider both the nursing and medical profes-
sions to hold equal and full jurisdiction over prescribing.
All the other countries imposed such stringent restric-
tions on nurses’ independent prescriptive authority via
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protocols and/or limited formularies of medicines, that
the medical profession still has exclusive full jurisdiction
over the prescribing task. Since nurses are often only
allowed to prescribe relatively harmless medication in
these countries, the medical profession has delegated to
them the ‘routine’ part of prescribing and remains in
control over the complex and professionally more
important part. Hence, nurses prescribe on the basis of
a subordinate jurisdiction.
Moreover, some countries such as Sweden not only
place restrictions on the medicines that nurses are
allowed to prescribe, but also on the type of patients for
whom nurses may prescribe. Because of the inclusion of
elements of client differentiation, we consider this an
even more restrictive form of subordinate jurisdiction,
thereby disputing Abbott’s assumption that client differ-
entiation is only a workplace settlement.
It is possible that these subordinate settlements of
nurse prescribing constitute phases in a process towards
shared full jurisdiction for the nursing profession. After
all, the road towards extensive prescribing rights for
nurses in the UK was also a gradual process, and we
note that in New Zealand prescriptive authority was
recently expanded to include the whole NP scope of
practice [5]. Nonetheless, movements in countries other
than the UK are generally slow. In some countries,
hardly any developments have been made since the
initial introduction of nurse prescribing, even though
nurse prescribing was sometimes introduced at a
(much) earlier point in time, such as in Sweden and the
USA.
Whereas all nine Western European and Anglo-Saxon
countries identified in this review have granted indepen-
dent prescribing authority to nurses, some of them
introduced other models of nurse prescribing as well,
resulting in a variety of jurisdictional settlements. The
requirements of several American states regarding phy-
sician involvement in nurse prescribing creates a model
of prescriptive authority comparable to supplementary
prescribing in the UK. In the Netherlands specific cate-
gories of specialist nurses will in the future also pre-
scribe through a model resembling supplementary
prescribing. Because of the clear distinction between
areas of responsibility, we consider both supplementary
prescribing and collaborative/supervised prescribing as
forms of prescribing within a ‘full division of labor’, in
Abbott’s terms. PGDs and medical directives, on the
contrary, are developed by a multidisciplinary team and
a physician respectively, while the nurse is the one who
uses them in daily practice. Hence, the ‘intellectual juris-
diction’ over the prescribing task lies with the
developers.
Applying Abbott’s classification system of jurisdic-
tional settlements to the prescribing scope of nurses in
Western European and Anglo-Saxon countries, it is
clear that the jurisdiction over the prescribing task in
most countries, apart from the UK and Ireland, remains
predominantly with the medical profession.
Mechanisms
In view of the extensive prescribing privileges that
nurses in Ireland and especially the UK enjoy, it is
remarkable that requirements concerning number of
years of clinical experience and educational level in
these two countries proved less stringent than in other
Western-European and Anglo-Saxon countries. Nurse
prescribing training in the UK and Ireland is taught at
(Honours) degree level and three years of clinical experi-
ence are required, whereas in most other countries
where nurse prescribing was or is being introduced,
nurses are trained at Master degree level. The number
of years of clinical experience required is also higher in
some countries, for example in New Zealand and Aus-
tralia, where the limit is set at four and five years
respectively. As Abbott states, internal and external
forces shape professional competition over jurisdiction.
In the UK and Ireland the emphasis was on enhancing
efficiency when introducing nurse prescribing, i.e. striv-
ing for quicker and more efficient patient access to
medicines and better use of health professionals’ skills
and knowledge. In other countries, however, more
urgent internal needs such as a shortage of physicians
and unmet medication needs of patients in remote areas
were the most important reasons for introducing nurse
prescribing. Forces focussing on efficiency seem to lead
to more extensive prescribing rights, at least for nurses
in Ireland and the UK. This would appear to confirm
Abbott’s assumption that external and internal forces
shape professional competition over jurisdiction. How-
ever, because of our focus on nurse prescribing, alterna-
tives to prescribing, such as statutory exemptions and
emergency provisions, were mainly left out of this
review. Nevertheless, their possible presence across
countries might have influenced the conditions under
which nurse prescribing was realized as well, in addition
to the influence of the internal and external forces we
examined.
Perhaps the question as to whether or not national
medical associations support the nurse prescribing
initiative is also important when it comes to nurses’ pre-
scriptive authority. It is established that the British Med-
ical Association in the UK has supported the nurse
prescribing initiative from the outset [85] and this may
have been beneficial to its extensive roll out. By con-
trast, in Australia, Spain and the USA, professional med-
ical organizations have mainly opposed nurse
prescribing [5,85,96], which may equally explain the
relatively limited prescribing rights of US nurses,
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especially in view of the much longer period of familiar-
ity with nurse prescribing in the USA compared to the
UK.
However, on the basis of current data no definitive
conclusions can be drawn about underlying mechanisms
that operate between the forces that led to the introduc-
tion of nurse prescribing internationally and the scope
of prescribing rights nurses enjoy. It would be interest-
ing to further examine these mechanisms, preferably in
a quantitative manner. Data on the percentage of total
healthcare expenditure on medicines, number of physi-
cians per capita and time of introduction of nurse pre-
scribing could for example be used in an ecological
analysis.
Gaps in the literature
An interesting finding in this review is the near absence
in the literature of reference to practice-related and
organizational conditions under which nurses are
allowed to prescribe medicines. This hinders a compari-
son and further theoretical interpretation of the organi-
zation of nurse prescribing internationally. For example,
even though we found that most countries have manda-
tory registration systems in place for nurse prescribers,
it remains unclear whether all nurses have individually
registered provider numbers. However, where prescrib-
ing has been introduced to improve cost-effectiveness,
individual provider numbers are needed to thoroughly
monitor who prescribes which medicines how often and
ascertain whether the implementation of nurse prescrib-
ing has had its intended effect.
When it comes to financial issues, likewise, many
questions remain unanswered in the literature. What
became clear however, is that reimbursement issues are
not always properly catered for and this can, even with
an otherwise good organisation, have far-reaching con-
sequences for the success of nurse prescribing. For
example, where medicines prescribed by nurses are not
(fully) covered by insurance providers and/or national
health programs, such as in some American states, this
can generate an unfavourable reaction from the public
towards nurse prescribing. Patients will prefer their phy-
sician to write their prescriptions, as reimbursement
issues for this profession are well arranged. Conse-
quently nurses might lose part of their workplace juris-
diction to the medical profession, who in their turn will
claim more legal jurisdiction. Moreover, the fact that
nurses’ prescriptions are not always eligible for reimbur-
sement underlines once more the full jurisdiction that
medicine still has over prescribing, despite nurses’ (lim-
ited) independent prescribing rights.
While we do not say that the organizational condi-
tions have not been properly addressed across countries,
they are largely missing from the literature. Both for
interpreting the organization of nurse prescribing on a
theoretical basis and for critically monitoring whether
expected goals are being met, it is important that orga-
nizational conditions - as much as educational and legal
conditions - are extensively discussed in the nurse pre-
scribing literature.
Limitations
It could be argued that this systematic review does not
give a complete picture of the state of the art, as a num-
ber of policy documents and other relevant grey litera-
ture might potentially have been excluded from the
review by our choice of search strategy. We choose this
strategy, however, to safeguard the quality of sources.
Even though the number of references to the organiza-
tional conditions under which nurses prescribe medi-
cines as identified in this review proved somewhat
disappointing, it is unlikely that this is due to our search
strategy, as the educational and legal conditions under
which nurses are allowed to prescribe medicines were
sufficiently addressed in the identified literature.
Furthermore, as nurse prescribing is still in the pro-
cess of development, there is a possibility that some of
the included literature may be out of date in certain
respects or doesn’t contain the most recent develop-
ments in nurse prescribing. We tried to prevent this by
including only publications from 2005 onwards that dis-
cussed the legal, educational and organizational condi-
tions under which nurses are allowed to prescribe
medicines. Nevertheless, it might prove beneficial to
conduct a further survey among relevant stakeholders
across all Western European and Anglo-Saxon countries
that have realised or initiated nurse prescribing. This
might also shed light on information that was largely
missing from the scientific and professional literature,
such as the organizational conditions under which nurse
prescribing has been or will be realised internationally.
Challenges for future research
Future research should provide more insight into the
organizational and more especially the financial condi-
tions under which nurses prescribe. These are not only
important in everyday practice but are also indicators
for the potential efficiency of nurse prescribing. There is
also a need for more theory-based research on nurse
prescribing. For example, we do not know how nurses’
legal and workplace jurisdictions over prescribing relate
to each other once legal prescriptive authority is
obtained. There are indications that qualified nurse pre-
scribers in the UK are not (fully) using their legal pre-
scribing rights on the work floor, partly because of their
own uncertainty about their educational preparation and
partly resulting from organizational conditions such as a
lack of system change within their work environment
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[36]. Future research should address this discrepancy
between obtained legal authority and workplace jurisdic-
tion. It is important to examine which mechanisms and
forces influence this relationship.
Conclusions
A diversity of external and internal forces has led to the
introduction of nurse prescribing internationally. The
precise nature of legal, educational and organizational
conditions for nurse prescribing varies considerably,
from situations where nurses prescribe independently to
situations in which prescribing by nurses is only allowed
under strict conditions and close supervision by physi-
cians. As a result, a variety of jurisdictional settlements
between the nursing and medical professions concerning
the task of prescribing can be discerned. In some coun-
tries, nurses share (full) jurisdiction with the medical pro-
fession, whereas in others nurses prescribe in a
subordinate position. However, in most countries the jur-
isdiction over prescribing remains predominantly with
the medical profession. There seems to be an underlying
mechanism linking the jurisdictional settlements between
professions with the forces that led to the introduction of
nurse prescribing. Forces focussing on efficiency appear
to lead to more extensive prescribing rights.
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